
Bioorganic and Medicinal Chemistry Letters p. 881 - 886 (1997)
Update date:2022-08-04
Topics:
Peglion, Jean-Louis
Vian, Joel
Goument, Bertrand
Despaux, Nicole
Audinot, Valerie
Millan, Mark J.
Starting from the structure of the preferential D3 antagonist S 14297 (1), we have prepared a series of cis and trans tetracyclic derivatives of general formula I in order to improve potency and selectivity for D3 receptors. The trans oxazino derivative 2c, showed slightly increased affinity at D3 receptors and double the selectivity for D3 over D2 receptors, in comparison to S 14297. Cis derivatives and compounds where R1 is aralkyl were totally devoid of activity.
View MoreFujian Huitian Biological Pharmacy Co., Ltd.
Contact:0086-598-8300831; 8339920
Address:No.46,Taijiang Road,Sanming City,Fujian,China
JIANGXI XINXIN CHEMICAL CO., LTD.
Contact:86-15957176628
Address:INDUSTRY ROAD 1, INDUSTRIAL PARK, HEKOU TOWN,YANSHAN COUNTY, JIANGXI PROVINCE, CHINA
Shantou Baokang Pharmaceutical Co., Ltd.
Contact:+86-754-88873487
Address:5/F B Block Huangshan Bldg Huangshan Rd Shantou
Contact:0792-8228321
Address:10TH Floor No.121 binjiang Road Xunyang District
Hangzhou LINGEBA Technology Co., Ltd.
Contact:+0086-571-87389059
Address:Office 1-913,NewYouth Plaza, GongShu Area, HangZhou,ZheJiang,P.R.China
Doi:10.1016/S0014-827X(99)00017-8
(1999)Doi:10.1016/j.poly.2010.12.049
(2011)Doi:10.1016/j.tetlet.2008.03.138
(2008)Doi:10.1039/DT9900002321
(1990)Doi:10.1002/ardp.200400884
(2004)Doi:10.1016/j.bmcl.2011.02.058
(2011)